Microneedle Delivery of Amphotericin B Shows Promise for American Cutaneous Leishmaniasis Treatment
Microneedle-based delivery of Amphotericin B significantly reduced lesion growth in mice with American cutaneous leishmaniasis.
Therapeutic Area
Therapeutic area intelligence for Leishmaniasis with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.